CORMEDIX INC's ticker is and the CUSIP is 21900C908. A total of 3 filers reported holding CORMEDIX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,210 | +22.9% | 13,300 | +31.7% | 0.00% | – |
| Q2 2023 | $40,047 | -15.1% | 10,100 | -11.4% | 0.00% | – |
| Q1 2023 | $47,196 | -67.8% | 11,400 | -67.1% | 0.00% | – |
| Q4 2022 | $146,434 | +205.1% | 34,700 | +105.3% | 0.00% | – |
| Q3 2022 | $48,000 | -15.8% | 16,900 | +18.2% | 0.00% | – |
| Q2 2022 | $57,000 | -53.7% | 14,300 | -36.2% | 0.00% | – |
| Q1 2022 | $123,000 | +2360.0% | 22,400 | +2140.0% | 0.00% | – |
| Q4 2021 | $5,000 | -89.8% | 1,000 | -90.6% | 0.00% | – |
| Q3 2021 | $49,000 | -92.2% | 10,600 | -88.4% | 0.00% | -100.0% |
| Q2 2021 | $628,000 | +9.8% | 91,500 | +59.7% | 0.00% | 0.0% |
| Q1 2021 | $572,000 | +109.5% | 57,300 | +56.1% | 0.00% | – |
| Q4 2020 | $273,000 | +92.3% | 36,700 | +55.5% | 0.00% | – |
| Q3 2020 | $142,000 | +49.5% | 23,600 | +57.3% | 0.00% | – |
| Q2 2020 | $95,000 | +458.8% | 15,000 | +212.5% | 0.00% | – |
| Q1 2020 | $17,000 | -77.6% | 4,800 | -53.8% | 0.00% | -100.0% |
| Q4 2019 | $76,000 | -65.8% | 10,400 | -70.1% | 0.00% | -50.0% |
| Q3 2019 | $222,000 | -81.8% | 34,800 | -74.4% | 0.00% | -81.8% |
| Q2 2019 | $1,218,000 | -61.8% | 135,800 | -59.8% | 0.01% | -69.4% |
| Q1 2019 | $3,192,000 | – | 337,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 11,400 | $47,196 | 0.00% |
| SIMPLEX TRADING, LLC | 28,100 | $116 | 0.00% |